Scribd
Upload
225 views11 pages

Organization Structure of Hul: Presented By:-Lavesh Sethia

The document provides an organizational structure and financial performance summary of Hindustan Unilever Limited (HUL) for the years 2018-19, 2019-20 and 2020-21. HUL has a Chairman who oversees various directors leading different business functions. It also has a Board of Directors and a Management Committee. Financially, HUL saw steady growth in gross sales, profits, and dividends per share over the years except for some ratios and EVA declining in 2020-21 potentially due to the merger with GSK Consumer Healthcare.

Uploaded by

Lavesh Sethia
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
225 views11 pages

Organization Structure of Hul: Presented By:-Lavesh Sethia

The document provides an organizational structure and financial performance summary of Hindustan Unilever Limited (HUL) for the years 2018-19, 2019-20 and 2020-21. HUL has a Chairman who oversees various directors leading different business functions. It also has a Board of Directors and a Management Committee. Financially, HUL saw steady growth in gross sales, profits, and dividends per share over the years except for some ratios and EVA declining in 2020-21 potentially due to the merger with GSK Consumer Healthcare.

Uploaded by

Lavesh Sethia
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 11

ORGANIZATION

STRUCTURE OF HUL
P R E S E N T E D B Y: -
L AV E S H S E T H I A
ORGANIZATION STRUCTURE OF
HINDUSTAN UNILEVER LIMITED

Chairman

Director Director Director Director Director HR


finance marketing technical
exports research

Director, legal Director Director Director Director


& secretarial beverages personal detergent ICFD
products
BOARD OF DIRECTORS

Mr. Sanjiv Mehta (Chairman and


Managing Director)

Mr. Srinivas Phatak (Executive Director,


Finance & IT and Chief Financial Officer)

Mr. Dev Bajpai (Executive Director, Legal &


Corporate Affairs and Company Secretary)
Mr. Wilhelmus Uijen (Executive Director,
Supply Chain)

Mr. O. P. Bhatt (Independent Director)

Dr. Sanjiv Misra (Independent


Director)
Ms. Kalpana Morparia (Independent
Director)

Mr. Leo Puri (Independent


Director)

Dr. Ashish Gupta


(Independent Director)
MANAGEMENT COMMITTEE

Mr. Sanjiv Mehta (Chairman and


Managing Director)

Mr. Srinivas Phatak (Executive Director,


Finance & IT and Chief Financial Officer)

Mr. Dev Bajpai (Executive Director, Legal &


Corporate Affairs and Company Secretary)
Mr. Wilhelmus Uijen (Executive Director,
Supply Chain)

Ms. Priya Nair (Executive Director,


Beauty & Personal Care)

Mr. Sudhir Sitapati (Executive Director, Foods &


Refreshment)
Mr. Srinandan Sundaram (Executive Director,
Sales and Customer Development)

Ms. Anuradha Razdan (Executive Director,


Human Resources)

Dr. Vibhav Sanzgiri (Executive Director,


Research & Development)

Ms. Prabha Narasimhan (Executive


Director, Home Care)
FINANCIAL PERFORMANCE

Statement of Profit & Loss Account 2018-19 2019-20 2020-21

45,311
Gross Sales 37,660 38,273

Other Income (includes other operating income) 1,228 1,245 1,198

Finance Cost (28) (106) (108)

Profit Before Taxation@ 8,749 9,289 10,717

Profit After Taxation@ 6,080 6,743 7,963

Earnings Per Share of `1 27.89 31.13 33.85

22.00 25.00 40.50$


Dividend Per Share of `1
Balance Sheet 2018-19 2019-20 2020-21

Property, Plant and Equipment and Intangible Assets 4,716 5,569 51,650

Investments 2,949 1,500 2,995

Cash and Other Bank Balances 3,688 5,017 4,321

Net Assets (Current and Non–Current) (3,694) (4,055) (11,532)

7,659 8,031 47,434

Share Capital 216 216 235

Other Equity 7,443 7,815 47,199

7,659 8,031 47,434

Key Ratios and EVA 2018-19 2019-20 2020-21

EBITDA (% of Gross Sales) 22.9 25.1 25.0

Fixed Asset Turnover (No. of Times) 8.0 6.9 0.9

PAT@/Gross Sales (%) 16.1 17.6 17.6

Return on Capital Employed (%) 131.2 128.5 22.9*

Return on Net Worth (%) 90.5 92.0 17.0*

Economic Value Added (EVA) (` crores) 5,291 6,085 3,810*

@ Before Exceptional items *Opening balances adjusted for GSK CH merger    

You might also like